OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,247 | -39.1% | 397 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $2,049 | -2.1% | 397 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,092 | +87.5% | 397 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $1,116 | -44.2% | 397 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,000 | 0.0% | 397 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | 0.0% | 397 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $2,000 | -33.3% | 397 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -25.0% | 397 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $4,000 | -33.3% | 397 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $6,000 | -14.3% | 397 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $7,000 | -12.5% | 397 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $8,000 | -55.6% | 397 | -83.4% | 0.01% | -56.2% |
| Q3 2020 | $18,000 | -10.0% | 2,397 | 0.0% | 0.02% | -27.3% |
| Q2 2020 | $20,000 | +81.8% | 2,397 | 0.0% | 0.02% | +69.2% |
| Q1 2020 | $11,000 | +22.2% | 2,397 | 0.0% | 0.01% | +30.0% |
| Q4 2019 | $9,000 | – | 2,397 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |